Characterizing and Predicting Drug Effects on Cognition

Trial Profile

Characterizing and Predicting Drug Effects on Cognition

Phase of Trial: Phase IV

Latest Information Update: 22 Sep 2016

At a glance

  • Drugs Topiramate (Primary) ; Lorazepam
  • Indications Anxiety disorders; Lennox-Gastaut syndrome; Migraine; Nausea and vomiting; Obesity; Post-traumatic stress disorders
  • Focus Pharmacodynamics; Pharmacokinetics
  • Acronyms CPDEC
  • Most Recent Events

    • 13 Sep 2016 Status changed from recruiting to completed.
    • 10 Jan 2014 Status changed from not yet recruiting to recruiting, according to record.
    • 17 Aug 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top